![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/paladin-releases-playbook--resource-repository-to-support-more-effective-patient-advocacy-group--biopharmaceutical-company-collaborations-302081885.html
https://www.prnewswire.com/news-releases/endos-paladin-labs-announces-launch-of-xcopri-cenobamate-tablets-in-canada-302041122.html
https://www.pharmaceutical-technology.com/news/health-canada-paladin-seizure/
https://finance.yahoo.com/news/paladin-labs-announces-launch-xydalba-123000837.html
https://www.prnewswire.com/news-releases/endo-announces-licensing-agreement-for-paladin-labs-inc-to-commercialize-abaloparatide-in-canada-301201070.html
http://www.prnewswire.com/news-releases/veloxis-pharmaceuticals-as-and-endo-ventures-limited-jointly-announce-agreement-for-paladin-labs-inc-to-commercialize-envarsus-xr-in-canada-300469735.html
http://www.reuters.com/article/us-endo-intl-divestiture-knight-therapeu-idUSKBN12Z1WN?rpc=401
http://www.wsj.com/articles/meet-pharmas-newest-movers-and-shakers-1429750065
http://www.fiercepharma.com/story/endo-said-be-jousting-valeant-shire-win-salix/2015-02-17